These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9890517)

  • 1. Purity of biological products: related and unrelated impurities.
    Herman AC
    Dev Biol Stand; 1998; 96():57-62. PubMed ID: 9890517
    [No Abstract]   [Full Text] [Related]  

  • 2. Purified protein products of rDNA technology expressed in animal cell culture.
    Lubiniecki AS; Lupker JH
    Biologicals; 1994 Jun; 22(2):161-9. PubMed ID: 7522477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of potency for well characterized biotechnology proteins.
    Finbloom DS
    Dev Biol Stand; 1998; 96():63-4. PubMed ID: 9890518
    [No Abstract]   [Full Text] [Related]  

  • 4. Definition of a well-characterized biotechnology product.
    Zoon K; Garnick R
    Dev Biol Stand; 1998; 96():191-7. PubMed ID: 9890531
    [No Abstract]   [Full Text] [Related]  

  • 5. Isolation, nucleotide sequence and expression of a cDNA encoding feline granulocyte colony-stimulating factor.
    Dunham SP; Onions DE
    Cytokine; 2001 Jun; 14(6):347-51. PubMed ID: 11497496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The quality control of biotechnology products.
    Federici MM
    Biologicals; 1994 Jun; 22(2):151-9. PubMed ID: 7917231
    [No Abstract]   [Full Text] [Related]  

  • 7. Nerve growth factor from Vipera lebetina venom.
    Paalme V; Trummal K; Samel M; Tõnismägi K; Järvekülg L; Vija H; Subbi J; Siigur J; Siigur E
    Toxicon; 2009 Sep; 54(3):329-36. PubMed ID: 19463841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of recombinant DNA technology in the production of glycosylated recombinant human granulocyte colony stimulating factor.
    Holloway CJ
    Eur J Cancer; 1994; 30A Suppl 3():S2-6. PubMed ID: 7535067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are hepatocyte growth factor-like protein and macrophage stimulating protein the same protein?
    Bezerra JA; Han S; Danton MJ; Degen SJ
    Protein Sci; 1993 Apr; 2(4):666-8. PubMed ID: 8518737
    [No Abstract]   [Full Text] [Related]  

  • 10. [Production of human G-CSF and its derivatives by recombinant DNA technology].
    Itoh S
    Tanpakushitsu Kakusan Koso; 1990 Oct; 35(14):2620-31. PubMed ID: 1702549
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of product comparability.
    Builder SE
    Dev Biol Stand; 1998; 96():83-90. PubMed ID: 9890520
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemical modification and site-directed mutagenesis of methionine residues in recombinant human granulocyte colony-stimulating factor: effect on stability and biological activity.
    Lu HS; Fausset PR; Narhi LO; Horan T; Shinagawa K; Shimamoto G; Boone TC
    Arch Biochem Biophys; 1999 Feb; 362(1):1-11. PubMed ID: 9917323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide mapping of recombinant proteins.
    Rohde MF; Lu HS; Rush RS
    Dev Biol Stand; 1994; 83():121-7. PubMed ID: 7533730
    [No Abstract]   [Full Text] [Related]  

  • 14. Purification and characterization of the biologically active human truncated macrophage colony-stimulating factor expressed in Saccharomyces cerevisiae.
    Zhu DX; Hua ZC; Liang XF; Zhang XK; Ding Y; Zhu JQ; Han KK
    Biol Chem Hoppe Seyler; 1993 Sep; 374(9):903-8. PubMed ID: 8267882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European Regulatory guidance on virus safety of recombinant proteins, monoclonal antibodies and plasma derived medicinal products.
    Celis P; Silvester G
    Dev Biol (Basel); 2004; 118():3-10. PubMed ID: 15645667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. USAN Council. List No. 340. New names. Lenograstim.
    Clin Pharmacol Ther; 1992 Jul; 52(1):113. PubMed ID: 1284891
    [No Abstract]   [Full Text] [Related]  

  • 17. Granulocyte colony-stimulating factor and its receptor in normal hematopoietic cell development and myeloid disease.
    van de Geijn GJ; Aarts LH; Erkeland SJ; Prasher JM; Touw IP
    Rev Physiol Biochem Pharmacol; 2003; 149():53-71. PubMed ID: 12687405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endotoxin removal and prevention for pre-clinical biologics production.
    Serdakowski London A; Kerins B; Tschantz WR; Eisfeld J; Mackay K
    Biotechnol J; 2012 Dec; 7(12):1509-16. PubMed ID: 23081824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel aqueous two phase assisted platform for efficient removal of process related impurities associated with E. coli based biotherapeutic protein products.
    Bhambure R; Sharma R; Gupta D; Rathore AS
    J Chromatogr A; 2013 Sep; 1307():49-57. PubMed ID: 23921264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renaturation of Escherichia coli-derived recombinant human macrophage colony-stimulating factor.
    Tran-Moseman A; Schauer N; De Bernardez Clark E
    Protein Expr Purif; 1999 Jun; 16(1):181-9. PubMed ID: 10336876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.